Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 167Triple Negative Breast Neoplasms 14Neoplasm Metastasis 13Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Breast Neoplasms, Male 5Brain Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3HER2-positive Advanced Breast Cancer 3Advanced Breast Cancer 3Small Cell Lung Carcinoma 2Sarcoma 2Pancreatic Neoplasms 2Lung Neoplasms 2HER2-negative Breast Cancer 2HER2 Positive Breast Cancer 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Recurrence 1Primary Breast Cancer 1Pheochromocytoma 1Patient Acceptance of Health Care 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Paraganglioma, Extra-Adrenal 1Metastatic HER2-positive Breast Cancer 1Meningeal Carcinomatosis 1Lymphoma, Non-Hodgkin 1Inflammatory Breast Neoplasms 1Hormone Receptor Positive Advanced Breast Cancer 1

Interventions

Fulvestrant 19Letrozole 10Anastrozole 8Capecitabine 5palbociclib 4olaparib 4Paclitaxel 4Injections 4Goserelin 4Docetaxel 4trastuzumab deruxtecan 3pyrotinib 3exemestane 3Vinorelbine 3Aromatase Inhibitors 3toripalimab 2sacituzumab govitecan 2ribociclib 2eribulin 2elacestrant 2dalpiciclib 2abemaciclib 2Trastuzumab 2Gonadotropin-Releasing Hormone 2FCN-437c 2Everolimus 2Dasatinib 2Alpelisib 2Albumin-Bound Paclitaxel 2AZD9833 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Vinorelbine × Breast × Clear all
NCT06500494 2025-07-24

VINOREAL

Pierre Fabre Medicament

Recruiting
368 enrolled
Breast

Advanced Breast Cancer

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase â…¡ Clinical Trial

Henan Cancer Hospital

Phase 2 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

NCT04304352 2023-06-28

VEX

European Institute of Oncology

Phase 2 Unknown
162 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡